Drug companies warm up to continuous manufacturing
Synthesizing the ingredients with continuous technologies, such as processes that incorporate photochemistry, cryogenic/exothermic chemistry and other techniques, offers capabilities not readily available in batch processes
By American Chemical Society —— Bio and Archives--May 3, 2019
Health and Medicine | Comments | Back To Full Article
For decades, most industries, from petrochemicals to paper, have embraced continuous manufacturing processes. In contrast, the ultraconservative pharmaceutical industry has remained committed to batch operations. But recently, the demands of chemically complex and targeted drugs coming to market have caused many pharmaceutical companies to rethink the way they make medicines, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy